vs
Side-by-side financial comparison of KILROY REALTY CORP (KRC) and Nutex Health, Inc. (NUTX). Click either name above to swap in a different company.
KILROY REALTY CORP is the larger business by last-quarter revenue ($272.2M vs $151.7M, roughly 1.8× Nutex Health, Inc.). Nutex Health, Inc. runs the higher net margin — 7.8% vs 6.3%, a 1.5% gap on every dollar of revenue. On growth, KILROY REALTY CORP posted the faster year-over-year revenue change (-5.0% vs -41.1%). KILROY REALTY CORP produced more free cash flow last quarter ($450.3M vs $69.0M). Over the past eight quarters, Nutex Health, Inc.'s revenue compounded faster (50.0% CAGR vs -1.2%).
Kilroy Realty Corp is a leading U.S. real estate investment trust that develops, owns, and operates premium office, life science, and mixed-use properties primarily across high-growth West Coast markets including Los Angeles, San Francisco, Seattle, and San Diego. It serves tenants across the technology, life sciences, media, and creative sectors, with a core focus on delivering sustainable, future-ready workspaces tailored to modern business needs.
Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.
KRC vs NUTX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $272.2M | $151.7M |
| Net Profit | $17.1M | $11.8M |
| Gross Margin | — | 30.4% |
| Operating Margin | — | 20.4% |
| Net Margin | 6.3% | 7.8% |
| Revenue YoY | -5.0% | -41.1% |
| Net Profit YoY | -73.7% | -80.8% |
| EPS (diluted) | $0.11 | $2.34 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $272.2M | $151.7M | ||
| Q3 25 | $279.7M | $267.8M | ||
| Q2 25 | $289.9M | $244.0M | ||
| Q1 25 | $270.8M | $211.8M | ||
| Q4 24 | $286.4M | $257.6M | ||
| Q3 24 | $289.9M | $78.8M | ||
| Q2 24 | $280.7M | $76.1M | ||
| Q1 24 | $278.6M | $67.5M |
| Q4 25 | $17.1M | $11.8M | ||
| Q3 25 | $162.3M | $55.4M | ||
| Q2 25 | $79.6M | $-17.7M | ||
| Q1 25 | $43.7M | $21.2M | ||
| Q4 24 | $65.0M | $61.6M | ||
| Q3 24 | $57.7M | $-8.8M | ||
| Q2 24 | $54.5M | $-364.0K | ||
| Q1 24 | $55.7M | $-364.0K |
| Q4 25 | — | 30.4% | ||
| Q3 25 | — | 57.8% | ||
| Q2 25 | — | 51.2% | ||
| Q1 25 | — | 55.9% | ||
| Q4 24 | — | 55.0% | ||
| Q3 24 | — | 27.8% | ||
| Q2 24 | — | 29.7% | ||
| Q1 24 | — | 15.1% |
| Q4 25 | — | 20.4% | ||
| Q3 25 | — | 48.7% | ||
| Q2 25 | — | 13.8% | ||
| Q1 25 | — | 38.1% | ||
| Q4 24 | — | 44.4% | ||
| Q3 24 | — | 12.3% | ||
| Q2 24 | — | 7.0% | ||
| Q1 24 | — | 2.1% |
| Q4 25 | 6.3% | 7.8% | ||
| Q3 25 | 58.0% | 20.7% | ||
| Q2 25 | 27.4% | -7.3% | ||
| Q1 25 | 16.1% | 10.0% | ||
| Q4 24 | 22.7% | 23.9% | ||
| Q3 24 | 19.9% | -11.2% | ||
| Q2 24 | 19.4% | -0.5% | ||
| Q1 24 | 20.0% | -0.5% |
| Q4 25 | $0.11 | $2.34 | ||
| Q3 25 | $1.31 | $7.76 | ||
| Q2 25 | $0.57 | $-2.95 | ||
| Q1 25 | $0.33 | $3.33 | ||
| Q4 24 | $0.50 | $11.56 | ||
| Q3 24 | $0.44 | $-1.72 | ||
| Q2 24 | $0.41 | $-0.07 | ||
| Q1 24 | $0.42 | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $179.3M | $185.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $5.4B | $329.4M |
| Total Assets | $10.9B | $918.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $179.3M | $185.6M | ||
| Q3 25 | $372.4M | $166.0M | ||
| Q2 25 | $193.1M | $96.7M | ||
| Q1 25 | $146.7M | $84.7M | ||
| Q4 24 | $165.7M | $40.6M | ||
| Q3 24 | $625.4M | $46.9M | ||
| Q2 24 | $835.9M | $40.8M | ||
| Q1 24 | $855.0M | $30.0M |
| Q4 25 | $5.4B | $329.4M | ||
| Q3 25 | $5.5B | $317.2M | ||
| Q2 25 | $5.4B | $235.3M | ||
| Q1 25 | $5.4B | $176.9M | ||
| Q4 24 | $5.4B | $132.4M | ||
| Q3 24 | $5.4B | $60.4M | ||
| Q2 24 | $5.4B | $62.7M | ||
| Q1 24 | $5.4B | $63.0M |
| Q4 25 | $10.9B | $918.5M | ||
| Q3 25 | $11.0B | $964.5M | ||
| Q2 25 | $10.9B | $841.0M | ||
| Q1 25 | $10.9B | $761.9M | ||
| Q4 24 | $10.9B | $655.3M | ||
| Q3 24 | $11.4B | $438.5M | ||
| Q2 24 | $11.5B | $422.4M | ||
| Q1 24 | $11.6B | $404.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $566.3M | $70.4M |
| Free Cash FlowOCF − Capex | $450.3M | $69.0M |
| FCF MarginFCF / Revenue | 165.4% | 45.5% |
| Capex IntensityCapex / Revenue | 42.6% | 0.9% |
| Cash ConversionOCF / Net Profit | 33.10× | 5.95× |
| TTM Free Cash FlowTrailing 4 quarters | $833.0M | $245.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $566.3M | $70.4M | ||
| Q3 25 | $176.6M | $99.5M | ||
| Q2 25 | $143.7M | $27.3M | ||
| Q1 25 | $136.9M | $51.0M | ||
| Q4 24 | $541.1M | $54.0K | ||
| Q3 24 | $176.3M | $6.8M | ||
| Q2 24 | $88.7M | $13.3M | ||
| Q1 24 | $167.9M | $3.1M |
| Q4 25 | $450.3M | $69.0M | ||
| Q3 25 | $148.7M | $99.2M | ||
| Q2 25 | $118.4M | $26.5M | ||
| Q1 25 | $115.6M | $50.9M | ||
| Q4 24 | $440.8M | $-341.0K | ||
| Q3 24 | $147.2M | $6.2M | ||
| Q2 24 | $69.5M | $12.7M | ||
| Q1 24 | $151.9M | $2.3M |
| Q4 25 | 165.4% | 45.5% | ||
| Q3 25 | 53.1% | 37.0% | ||
| Q2 25 | 40.9% | 10.9% | ||
| Q1 25 | 42.7% | 24.0% | ||
| Q4 24 | 153.9% | -0.1% | ||
| Q3 24 | 50.8% | 7.8% | ||
| Q2 24 | 24.7% | 16.7% | ||
| Q1 24 | 54.5% | 3.4% |
| Q4 25 | 42.6% | 0.9% | ||
| Q3 25 | 10.0% | 0.1% | ||
| Q2 25 | 8.7% | 0.3% | ||
| Q1 25 | 7.9% | 0.0% | ||
| Q4 24 | 35.0% | 0.2% | ||
| Q3 24 | 10.1% | 0.8% | ||
| Q2 24 | 6.8% | 0.7% | ||
| Q1 24 | 5.7% | 1.1% |
| Q4 25 | 33.10× | 5.95× | ||
| Q3 25 | 1.09× | 1.80× | ||
| Q2 25 | 1.81× | — | ||
| Q1 25 | 3.13× | 2.40× | ||
| Q4 24 | 8.32× | 0.00× | ||
| Q3 24 | 3.06× | — | ||
| Q2 24 | 1.63× | — | ||
| Q1 24 | 3.01× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
KRC
Segment breakdown not available.
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |
